Trial Profile
Safety and Immunogenicity Among Adults of Fluzone Quadrivalent, Fluzone Intradermal Quadrivalent, and Fluzone High-Dose, Influenza Vaccines, 2015-2016 Formulations
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 14 Dec 2016
Price :
$35
*
At a glance
- Drugs Influenza virus vaccine (Primary) ; Influenza virus vaccine (Primary)
- Indications Influenza virus infections
- Focus Adverse reactions
- Sponsors Sanofi Pasteur
- 20 Oct 2016 Status changed from active, no longer recruiting to completed.
- 13 Oct 2015 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
- 05 Oct 2015 New trial record